The Noctura 400 Sleep Mask was effective in 96% of patients in an observational study conducted at Ashford and St Peter’s NHS Foundation Trust in Surrey, after which treatment was rolled out.
When a person is sleeping and it is dark outside, the eyes need more oxygen. In diabetic retinopathy, the retina at the back of the eye is deprived of oxygen and the eye tries to make new blood vessels to bring more oxygen.
However, these blood vessels are often weak and can leak fluid and blood, affecting vision. Common symptoms of diabetic retinopathy include sudden changes in vision, floaters, and double vision.
The Noctura 400 mask provides low levels of light while the patient is asleep to prevent increased oxygen demand in the eyes.
The company suggests that early use of masks for patients could save the NHS £3,000 per patient, which could grow to £180 million annually if adopted nationwide. I’m here.
An Ashford and St Peter’s trust 26-patient study published in the Journal of Ophthalmology showed that masks improved and stabilized diabetic eye disease in 96% of patients.
Bringing Hope to About 60,000 Patients
About 200 of the Trust’s early-stage patients will benefit from masks, but nationwide about 60,000 may benefit.
Treatment costs £1,000 per patient, while more invasive eye injections cost around £4,200.
It is understood that discussions are ongoing about deploying the device in 10 other trusts.
Ulrich Meyer-Bothling, Consultant Ophthalmologist at Ashford and St Peter’s Hospitals NHS Foundation Trust, said:
“For patients, it provides a painless treatment option for their condition. It is non-invasive, in effect, they receive treatment while they sleep.
“It also gives patients more time back without the need for frequent hospital visits. represents.”
